|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang JD, Hainaut P, Gores GJ, Amadou A,
Plymoth A and Roberts LR: A global view of hepatocellular
carcinoma: Trends, risk, prevention and management. Nat Rev
Gastroenterol Hepatol. 16:589–604. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Turajlic S and Swanton C: Metastasis as an
evolutionary process. Science. 352:169–175. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hase K, Shatney C, Johnson D, Trollope M
and Vierra M: Prognostic value of tumor ‘budding’ in patients with
colorectal cancer. Dis Colon Rectum. 36:627–635. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Koike M, Kodera Y, Itoh Y, Nakayama G,
Fujiwara M, Hamajima N and Nakao A: Multivariate analysis of the
pathologic features of esophageal squamous cell cancer: Tumor
budding is a significant independent prognostic factor. Ann Surg
Oncol. 15:1977–1982. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Luo WR, Gao F, Li SY and Yao KT: Tumour
budding and the expression of cancer stem cell marker aldehyde
dehydrogenase 1 in nasopharyngeal carcinoma. Histopathology.
61:1072–1081. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Masuda R, Kijima H, Imamura N, Aruga N,
Nakamura Y, Masuda D, Takeichi H, Kato N, Nakagawa T, Tanaka M, et
al: Tumor budding is a significant indicator of a poor prognosis in
lung squamous cell carcinoma patients. Mol Med Rep. 6:937–943.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Karamitopoulou E, Zlobec I, Born D,
Kondi-Pafiti A, Lykoudis P, Mellou A, Gennatas K, Gloor B and Lugli
A: Tumour budding is a strong and independent prognostic factor in
pancreatic cancer. Eur J Cancer. 49:1032–1039. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grigore AD, Jolly MK, Jia D, Farach-Carson
MC and Levine H: Tumor budding: The name is EMT. Partial EMT. J
Clin Med. 5:512016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
De Smedt L, Palmans S, Andel D, Govaere O,
Boeckx B, Smeets D, Galle E, Wouters J, Barras D, Suffiotti M, et
al: Expression profiling of budding cells in colorectal cancer
reveals an EMT-like phenotype and molecular subtype switching. Br J
Cancer. 116:58–65. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kairaluoma V, Kemi N, Pohjanen VM, Saarnio
J and Helminen O: Tumour budding and tumour-stroma ratio in
hepatocellular carcinoma. Br J Cancer. 123:38–45. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wei L, Delin Z, Kefei Y, Hong W, Jiwei H
and Yange Z: A classification based on tumor budding and immune
score for patients with hepatocellular carcinoma. Oncoimmunology.
9:16724952019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang D, Qian C, Wei H and Qian X:
Identification of the prognostic value of tumor
microenvironment-related genes in esophageal squamous cell
carcinoma. Front Mol Biosci. 7:5994752020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sakamoto N, Oue N, Noguchi T, Sentani K,
Anami K, Sanada Y, Yoshida K and Yasui W: Serial analysis of gene
expression of esophageal squamous cell carcinoma: ADAMTS16 is
upregulated in esophageal squamous cell carcinoma. Cancer Sci.
101:1038–1044. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mersakova S, Janikova K, Kalman M,
Marcinek J, Grendar M, Vojtko M, Kycina R, Pindura M, Janik J,
Mikolajcik P, et al: Cancer stem cell marker expression and
methylation status in patients with colorectal cancer. Oncol Lett.
24:2312022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Raida M, Clement JH, Ameri K, Han C, Leek
RD and Harris AL: Expression of bone morphogenetic protein 2 in
breast cancer cells inhibits hypoxic cell death. Int J Oncol.
26:1465–1470. 2005.PubMed/NCBI
|
|
18
|
Yang S, Pham LK, Liao CP, Frenkel B, Reddi
AH and Roy-Burman P: A novel bone morphogenetic protein signaling
in heterotypic cell interactions in prostate cancer. Cancer Res.
68:198–205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hsu YL, Huang MS, Yang CJ, Hung JY, Wu LY
and Kuo PL: Lung tumor-associated osteoblast-derived bone
morphogenetic protein-2 increased epithelial-to-mesenchymal
transition of cancer by Runx2/Snail signaling pathway. J Biol Chem.
286:37335–37346. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu G, Huang F, Chen Y, Zhuang Y, Huang Y
and Xie Y: High levels of BMP2 promote liver cancer growth via the
activation of myeloid-derived suppressor cells. Front Oncol.
10:1942020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Z, Sun J, Wang X and Cao Z:
MicroRNA-129-5p promotes proliferation and metastasis of
hepatocellular carcinoma by regulating the BMP2 gene. Exp Ther Med.
21:2572021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate-a practical and powerful approach to
multiple testing. J Roy Statist Soc B. 57:289–300. 1995.
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Scott RW, Crighton D and Olson MF:
Modeling and imaging 3-dimensional collective cell invasion. J Vis
Exp. 35252011.PubMed/NCBI
|
|
26
|
Pfisterer L and Korff T: Spheroid-based in
vitro angiogenesis model. Methods Mol Biol. 1430:167–177. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Muenst S, Läubli H, Soysal SD, Zippelius
A, Tzankov A and Hoeller S: The immune system and cancer evasion
strategies: Therapeutic concepts. J Intern Med. 279:541–562. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Aust S, Felix S, Auer K, Bachmayr-Heyda A,
Kenner L, Dekan S, Meier SM, Gerner C, Grimm C and Pils D: Absence
of PD-L1 on tumor cells is associated with reduced MHC I expression
and PD-L1 expression increases in recurrent serous ovarian cancer.
Sci Rep. 7:429292017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Baloche V, Rivière J, Tran TBT, Gelin A,
Bawa O, Signolle N, Diop MBK, Dessen P, Beq S, David M and Busson
P: Serial transplantation unmasks galectin-9 contribution to tumor
immune escape in the MB49 murine model. Sci Rep. 11:52272021.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liao J, Li JZ, Xu J, Xu Y, Wen WP, Zheng L
and Li L: High S100A9+ cell density predicts a poor
prognosis in hepatocellular carcinoma patients after curative
resection. Aging (Albany NY). 13:16367–16380. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liang F, Cao W, Wang Y, Li L, Zhang G and
Wang Z: The prognostic value of tumor budding in invasive breast
cancer. Pathol Res Pract. 209:269–275. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Prall F: Tumour budding in colorectal
carcinoma. Histopathology. 50:151–162. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Morodomi T, Isomoto H, Shirouzu K,
Kakegawa K, Irie K and Morimatsu M: An index for estimating the
probability of lymph node metastasis in rectal cancers. Lymph node
metastasis and the histopathology of actively invasive regions of
cancer. Cancer. 63:539–543. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ueno H, Murphy J, Jass JR, Mochizuki H and
Talbot IC: Tumour ‘budding’ as an index to estimate the potential
of aggressiveness in rectal cancer. Histopathology. 40:127–132.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mitrovic B, Schaeffer DF, Riddell RH and
Kirsch R: Tumor budding in colorectal carcinoma: Time to take
notice. Mod Pathol. 25:1315–1325. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Satoh K, Nimura S, Aoki M, Hamasaki M,
Koga K, Iwasaki H, Yamashita Y, Kataoka H and Nabeshima K: Tumor
budding in colorectal carcinoma assessed by cytokeratin
immunostaining and budding areas: Possible involvement of c-Met.
Cancer Sci. 105:1487–1495. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rogers AC, Gibbons D, Hanly AM, Hyland JM,
O'Connell PR, Winter DC and Sheahan K: Prognostic significance of
tumor budding in rectal cancer biopsies before neoadjuvant therapy.
Mod Pathol. 27:156–162. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li A and Machesky LM: Melanoblasts on the
move: Rac1 sets the pace. Small GTPases. 3:115–119. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gupta S and Maitra A: EMT: Matter of life
or death? Cell. 164:840–842. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yu M, Bardia A, Wittner BS, Stott SL, Smas
ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, et al:
Circulating breast tumor cells exhibit dynamic changes in
epithelial and mesenchymal composition. Science. 339:580–584. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li T, Zhou J, Jiang Y, Zhao Y, Huang J, Li
W, Huang Z, Chen Z, Tang X, Chen H and Yang Z: The novel protein
ADAMTS16 promotes gastric carcinogenesis by targeting IFI27 through
the NF-κb signaling pathway. Int J Mol Sci. 23:110222022.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wu CX, Lin GS, Lin ZX, Zhang JD, Chen L,
Liu SY, Tang WL, Qiu XX and Zhou CF: Peritumoral edema on magnetic
resonance imaging predicts a poor clinical outcome in malignant
glioma. Oncol Lett. 10:2769–2776. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Almishri W, Swain LA, D'Mello C, Le TS,
Urbanski SJ and Nguyen HH: ADAM metalloproteinase domain 17
regulates cholestasis-associated liver injury and sickness behavior
development in mice. Front Immunol. 12:7791192022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Guo J, Guo M and Zheng J: Inhibition of
BONE MORPHOGENETIC PROtein 2 suppresses the stemness maintenance of
cancer stem cells in hepatocellular carcinoma via the MAPK/ERK
pathway. Cancer Manag Res. 13:773–785. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zuo WH, Zeng P, Chen X, Lu YJ, Li A and Wu
JB: Promotive effects of bone morphogenetic protein 2 on
angiogenesis in hepatocarcinoma via multiple signal pathways. Sci
Rep. 6:374992016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Raida M, Clement JH, Leek RD, Ameri K,
Bicknell R, Niederwieser D and Harris AL: Bone morphogenetic
protein 2 (BMP-2) and induction of tumor angiogenesis. J Cancer Res
Clin Oncol. 131:741–750. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Renne SL, Woo HY, Allegra S, Rudini N,
Yano H, Donadon M, Viganò L, Akiba J, Lee HS, Rhee H, et al:
Vessels encapsulating tumor clusters (VETC) is a powerful predictor
of aggressive hepatocellular carcinoma. Hepatology. 71:183–195.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Rodriguez MI, Peralta-Leal A, O'Valle F,
Rodriguez-Vargas JM, Gonzalez-Flores A, Majuelos-Melguizo J, López
L, Serrano S, de Herreros AG, Rodríguez-Manzaneque JC, et al:
PARP-1 regulates metastatic melanoma through modulation of
vimentin-induced malignant transformation. PLoS Genet.
9:e10035312013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang MH, Zhou XM, Zhang MY, Shi L, Xiao
RW, Zeng LS, Yang XZ, Zheng XFS, Wang HY and Mai SJ: BMP2 promotes
proliferation and invasion of nasopharyngeal carcinoma cells via
mTORC1 pathway. Aging (Albany NY). 9:1326–1340. 2017. View Article : Google Scholar : PubMed/NCBI
|
